84 related articles for article (PubMed ID: 15780553)
41. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
42. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
43. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development.
Hummerich L; Müller R; Hess J; Kokocinski F; Hahn M; Fürstenberger G; Mauch C; Lichter P; Angel P
Oncogene; 2006 Jan; 25(1):111-21. PubMed ID: 16247483
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
45. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
[TBL] [Abstract][Full Text] [Related]
46. Role of thrombomodulin in cancer biology.
Iqbal S
Breast; 2000 Oct; 9(5):264-6. PubMed ID: 14732175
[TBL] [Abstract][Full Text] [Related]
47. Plasma thrombomodulin level in malignancy varies according to the tumor type.
Boffa MC; Lapeyrère C; Berard M; Lindahl AK; Flageul B; Chemaly P; Abildgaard U; Dubertret L
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S87-8. PubMed ID: 8177725
[TBL] [Abstract][Full Text] [Related]
48. Molecular Determinants of Statin-sensitivity in Cancer.
Fatehi Hassanabad A; Wong JVS
Am J Clin Oncol; 2020 Mar; 43(3):160-162. PubMed ID: 31842115
[No Abstract] [Full Text] [Related]
49. Group XIV C-type lectins: emerging targets in tumor angiogenesis.
Yee EJ; Vigil I; Sun Y; Torphy RJ; Schulick RD; Zhu Y
Angiogenesis; 2024 May; 27(2):173-192. PubMed ID: 38468017
[TBL] [Abstract][Full Text] [Related]
50. Crosstalk between Circulating Tumor Cells and Plasma Proteins-Impact on Coagulation and Anticoagulation.
Wang Y; Schneider SW; Gorzelanny C
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296987
[TBL] [Abstract][Full Text] [Related]
51. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
Bazzi ZA; Lanoue D; El-Youssef M; Romagnuolo R; Tubman J; Cavallo-Medved D; Porter LA; Boffa MB
BMC Cancer; 2016 May; 16():328. PubMed ID: 27221823
[TBL] [Abstract][Full Text] [Related]
52. A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H; Takami A; Espinoza JL; Matsuo K; Mizuno S; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Ohtake S; Morishita E
Int J Hematol; 2015 Oct; 102(4):460-70. PubMed ID: 26246110
[TBL] [Abstract][Full Text] [Related]
53. Thrombomodulin expression regulates tumorigenesis in bladder cancer.
Wu CT; Chang YH; Lin P; Chen WC; Chen MF
BMC Cancer; 2014 May; 14():375. PubMed ID: 24886404
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelial-mesenchymal transition.
Kao YC; Wu LW; Shi CS; Chu CH; Huang CW; Kuo CP; Sheu HM; Shi GY; Wu HL
Mol Cell Biol; 2010 Oct; 30(20):4767-85. PubMed ID: 20713448
[TBL] [Abstract][Full Text] [Related]
55. A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance.
Frederix K; Kooter IM; van Oerle R; Fens D; Hamulyak K; Gerlofs-Nijland ME; Ten Cate H; Spronk HM
Thromb J; 2008 Oct; 6():14. PubMed ID: 18828903
[TBL] [Abstract][Full Text] [Related]
56. Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival.
Hanly AM; Redmond M; Winter DC; Brophy S; Deasy JM; Bouchier-Hayes DJ; Kay EW
Br J Cancer; 2006 May; 94(9):1320-5. PubMed ID: 16622452
[TBL] [Abstract][Full Text] [Related]
57. Thrombomodulin: tumour biology and prognostic implications.
Hanly AM; Hayanga A; Winter DC; Bouchier-Hayes DJ
Eur J Surg Oncol; 2005 Apr; 31(3):217-20. PubMed ID: 15780553
[TBL] [Abstract][Full Text] [Related]
58. The role of thrombomodulin in malignancy.
Hanly AM; Winter DC
Semin Thromb Hemost; 2007 Oct; 33(7):673-9. PubMed ID: 18000794
[TBL] [Abstract][Full Text] [Related]
59. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
Séguin C; Abid MR; Spokes KC; Aird WC
Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
[TBL] [Abstract][Full Text] [Related]
60. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
